Exyn Technologies Inc (EXYN) Stock Analysis
Verdict: AVOID
Critical cash burn and negative equity ($11.3M deficit) pose acute dilution risk, overshadowing robotic mapping technology growth.
Investment score: 19/100
Analysis as of
Is Exyn Technologies Inc stock worth reviewing? AI model thesis
The AI model rates EXYN as AVOID due to immediate balance sheet insolvency risk, a 1.1-month cash runway, and severe net losses that make dilution imminent.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 30/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Exyn Technologies Inc opportunities and risks
What speaks for EXYN
- Proprietary GPS-denied autonomous drone software technology
What speaks against EXYN
- Existential liquidity crisis and cash runway depletion
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| EXYN | n/a | 8.2x | n/a | 44.3% | -473.4% | -40.4% |
| VWAV | n/a | 97.5x | n/a | -2877.6% | -15668.2% | -54.7% |
| VWAV | n/a | 97.5x | n/a | -2877.6% | -15668.2% | -54.7% |
| VTSI | n/a | 2.0x | n/a | 61.4% | -15.8% | -16.1% |
| OPST | 17.7x | 2.8x | 11.9x | 34.8% | 15.8% | 3.8% |
| ETCC | 17.3x | 0.3x | 4.5x | 27.4% | 3.2% | 20.5% |
| Peer median | n/a | 2.8x | n/a | 27.4% | -15.8% | -16.1% |
Frequently asked questions about Exyn Technologies Inc (EXYN)
Is EXYN stock a good investment?
The cached TradeMates AI model rates Exyn Technologies Inc as AVOID with an investment score of 19/100. The AI model rates EXYN as AVOID due to immediate balance sheet insolvency risk, a 1.1-month cash runway, and severe net losses that make dilution imminent. This is algorithmic model output, not personal investment advice.
Is EXYN stock a buy?
The TradeMates model verdict for EXYN is AVOID with an investment score of 19/100. Treat this as a model signal to review, not a personal buy recommendation.